Ethema Health Corporation
GRST · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.05 | 0.01 |
| FCF Yield | -14.98% | -51.02% | 85.11% | -8.08% |
| EV / EBITDA | -38.67 | 7.55 | 5.28 | 10.22 |
| Quality | ||||
| ROIC | -13.63% | -10.59% | 12.57% | 0.08% |
| Gross Margin | 100.00% | 87.35% | 75.96% | 90.79% |
| Cash Conversion Ratio | 0.21 | -0.45 | 5.34 | 0.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.67% | 40.12% | 142.28% | 75.42% |
| Free Cash Flow Growth | -32.45% | -145.25% | 677.50% | -114.18% |
| Safety | ||||
| Net Debt / EBITDA | -29.82 | 7.01 | 4.66 | 8.27 |
| Interest Coverage | -1.36 | -0.69 | 0.40 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 25.91 | 6.01 |
| Cash Conversion Cycle | 15.82 | -168.68 | -14.23 | -801.92 |